CTOs on the Move

Peninsula Community Mental Health Center

www.pcmhc.org

 
Peninsula Community Mental Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Peninsula Community Mental Health Center is based in Port Angeles, WA. You can find more information on Peninsula Community Mental Health Center at www.pcmhc.org
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pcmhc.org
  • 118 E 8th St
    Port Angeles, WA USA 98362
  • Phone: 360.457.0431

Executives

Name Title Contact Details

Similar Companies

Dental One Partners

Dental One Partners is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cleveland, OH. To find more information about Dental One Partners, please visit www.dentalonepartners.com

University Hospitals Rainbow Babies and Childrens Hospital

University Hospitals, one of the nation`s leading health care systems, focuses on providing compassionate, quality medical care to patients at convenient locations throughout Northeast Ohio.

Seaside Healthcare

Seaside Healthcare, our mission is to improve the lives of our patients and their communities through outcome-based, cost-effective mental-health services delivered with dignity and respect.

Physician Billing Service Bureau

Physician Billing Service Bureau is a Dearborn Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.